TCF/LEF1, a key transcription factor in canonical Wnt/β‐catenin signaling pathway, is overexpressed in HER‐2 negative breast cancers [46, 47] and has been implicated in brain metastasis through modulation of glutathione metabolism and ROS resistance [48]. Here, ERBB2 is linked to breast cancer.